Bentley Capital Limited

BEL

Bentley Capital Ltd is a AU-based company operating in industry. The company is headquartered in Perth, Western Australia. Bentley Capital Limited is an Australia-based investment company. The firm's primary objective is to generate absolute returns for the benefit of its shareholders. The company is focused on investing its capital into emerging companies with capital growth potential. The company generally take a substantial equity stake in selected companies and targets a small number of investments within the portfolio. The firm's segments include Investments and Corporate. The Investments segment comprises securities listed on the Australian Securities Exchange (ASX), units in unlisted managed funds and other liquid financial assets. The Corporate segment provides corporate assets and operations. The company is focused on investing in various sectors, such as resources, energy, technology and services.

Bendigo and Adelaide Bank Limited

BEN

Bendigo & Adelaide Bank Ltd. engages in banking and financial services including consumer, residential, business, rural and commercial lending, deposit-taking, payments and foreign exchange services, wealth management, margin lending, and superannuation, and treasury. The company is headquartered in Bendigo, Victoria and currently employs 4,682 full-time employees. The principal activities of the Company include the provision of a range of banking and other financial services, including consumer, residential, business, rural and commercial lending, deposit-taking, payments services, wealth management, margin lending, and superannuation, treasury, and foreign exchange services. Its Consumer segment is engaged in servicing its consumer customers and includes the branch network, Up digital bank, mobile relationship managers, third party banking channels, wealth services, Homesafe, and customer support functions. Its Business and Agribusiness segment is focused on servicing business customers, primarily small and medium businesses, who are seeking a relationship banking experience and includes portfolio funding, Delphi Bank, and all banking services provided to agribusiness, rural and regional Australian communities through the Rural Bank brand.

Birddog Technology Limited

BDT

BirdDog Technology Ltd. develops and manufactures audio-visual and video technology. The principal activities of the Company consist of development and manufacturing of global video technology that enhances the quality, speed and flexibility of video through a range of solutions, augmented with network device interface (NDI). These solutions are then sold through a network of distributors and resellers and direct, to individuals and organizations within professional video, corporate audio-visual (AV) and digital signage markets who demand broadcast quality video content. NDI uses software, computers and networks to make video creation and sharing accessible. The Company’s NDI Bridge transports complete NDI streams over local area network (LAN), wide area network (WAN) or public Internet. Its NDI Audio Direct makes audio-over-IP available for software-based audio applications.

Bcal Diagnostics Limited

BDX

BCAL Diagnostics Ltd. develops screening tests for the early detection of breast cancer. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-07-21. The Company’s principal activities include the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, including preparation for clinical trials. The company developed a blood screening test to be used alongside breast cancer screening methods. The technology initially complements imaging technologies, such as the mammogram, while it further progresses the development of a monitoring and screening test suitable for women of all ages and backgrounds in any location. Its BCAL test is a lipid biomarker blood (Breast Cancer Associated Lipids test) test with the potential to be used for breast cancer prevention, screening, and monitoring. The firm has partnered with Precion Inc. to optimize protocols and procedures for the clinical studies required for regulatory approvals across several jurisdictions.